Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| EQL Pharma AB | 771,815 | net | 12 Sept 2025 | tx 43+900,276−128,461 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Sept 2025 | SALE | EQL Pharma AB | 667 | 85.57 SEK | |
| 21 Aug 2025 | SALE | EQL Pharma AB | 10,000 | 81.34 SEK | |
| 20 Aug 2025 | SALE | EQL Pharma AB | 5,528 | 84.08 SEK | |
| 19 Aug 2025 | SALE | EQL Pharma AB | 2,054 | 86.07 SEK | |
| 18 Aug 2025 | SALE | EQL Pharma AB | 7,402 | 86.24 SEK | |
| 19 Jun 2025 | SALE | EQL Pharma AB | 2,810 | 92.98 SEK | |
| 28 Nov 2022 | SALE | EQL Pharma AB | 100,000 | 28.00 SEK | |
| 16 Dec 2020 | OTHER | EQL Pharma AB | 350,000 | 11.40 SEK | deriv |
| 19 Mar 2019 | PURCHASE | EQL Pharma AB | 50,000 | 1.34 SEK | deriv |
| 27 Nov 2018 | PURCHASE | EQL Pharma AB | 1,437 | 12.10 SEK | |
| 27 Nov 2018 | PURCHASE | EQL Pharma AB | 2,100 | 12.25 SEK | |
| 26 Nov 2018 | PURCHASE | EQL Pharma AB | 1,500 | 12.25 SEK | |
| 27 Nov 2018 | PURCHASE | EQL Pharma AB | 1,803 | 12.45 SEK | |
| 27 Nov 2018 | PURCHASE | EQL Pharma AB | 1,803 | 12.45 SEK | |
| 27 Nov 2018 | PURCHASE | EQL Pharma AB | 1,803 | 12.45 SEK | |
| 16 Nov 2018 | PURCHASE | EQL Pharma AB | 106 | 6.00 SEK | |
| 13 Nov 2018 | OTHER | EQL Pharma AB | 9,000 | 0.00 SEK | deriv |
| 13 Nov 2018 | PURCHASE | EQL Pharma AB | 1,500 | 6.00 SEK | |
| 16 Nov 2018 | PURCHASE | EQL Pharma AB | 25 | 6.00 SEK | anomaly |
| 13 Nov 2018 | OTHER | EQL Pharma AB | 2,300 | 0.00 SEK | deriv |
| 13 Nov 2018 | PURCHASE | EQL Pharma AB | 383 | 6.00 SEK | |
| 13 Nov 2018 | PURCHASE | EQL Pharma AB | 383 | 6.00 SEK | |
| 13 Nov 2018 | OTHER | EQL Pharma AB | 2,300 | 0.00 SEK | deriv |
| 13 Nov 2018 | OTHER | EQL Pharma AB | 2,300 | 0.00 SEK | deriv |
| 13 Nov 2018 | PURCHASE | EQL Pharma AB | 383 | 6.00 SEK |
1 purchase reported after at least 12 months of silence — most recent on 30 Oct 2018.